Rare side effects include nausea, fishy body odor (at high doses), or mild digestive upset
It has diverse clinical presentations including hypo- or hyperpigmented lines with or without atrophy along with milia, comedones, papules, pustules, nodules or firm white scars
Novo Nordisk Settles Ozempic Patent Case The Danish company Novo Nordisk and Viatris' Mylan Pharmaceuticals have settled their patent dispute before the Patent Trial and Appeal Board (PTAB or the Board) involving the weight-loss drugs Ozempic and Wegovy
Why Retatrutide Might Cause Dysesthesia Theory 1: Glucagon Receptor Activation Retatrutide is the first triple agonist activating glucagon receptors along with GLP-1 and GIP
Ethics declarations Competing interests The funder (House Wellness Foods Corporation) provided support in the form of salaries for an author (N.Y.), but did not have any role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript